SCHEMBL19861306

SCHEMBL19861306

CCCCCCC(C)(C)CCCC(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.64
PPARG P37231 7/20 0.64
PPARD Q03181 7/20 0.64
PPARA Q07869 7/20 0.64
HDAC11 Q96DB2 5/20 0.64
TSHR P16473 4/20 0.64
PTPN1 P18031 3/20 0.64
TDP1 Q9NUW8 3/20 0.64
FABP4 P15090 3/20 0.64
ALDH1A1 P00352 2/20 0.64
TLR2 O60603 2/20 0.64
KMT2A Q03164 2/20 0.64
FFAR1 O14842 2/20 0.64
ALOX15 P16050 2/20 0.64
HSD17B10 Q99714 2/20 0.64
SLC22A6 Q4U2R8 1/20 0.64
SLC22A8 Q8TCC7 1/20 0.64
MEN1 O00255 1/20 0.64
ESR1 P03372 1/20 0.64
PDE4A P27815 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19861449 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8039123 0.96 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL28415946 0.96 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5878877 0.96 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL20076148 0.96 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19861220 0.96 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19861428 0.96 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1116137 0.92 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1116131 0.92 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7864001 0.92 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200354384-A1 HETEROARYL INHIBITORS OF PDE4 Tetra Discovery Partners, LLC 2020-11-12 US disclosed
US-10364258-B2 Heteroaryl inhibitors of PDE4 Tetra Discovery Partners, LLC (US) 2019-07-30 US disclosed
US-20190055269-A1 HETEROARYL INHIBITORS OF PDE4 Tetra Discovery Partners, LLC 2019-02-21 US disclosed
US-9890198-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2018-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354384-A1 HETEROARYL INHIBITORS OF PDE4 PDE4A, PDE4B, PDE4C GPR84 547/4885PPARG 719/4885PPARD 684/4885
US-20190055269-A1 HETEROARYL INHIBITORS OF PDE4 PDE4A, PDE4B, PDE4C GPR84 547/4885PPARG 719/4885PPARD 684/4885
US-10364258-B2 Heteroaryl inhibitors of PDE4 PDE4A, PDE4B, PDE4C GPR84 547/4885PPARG 719/4885PPARD 684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.